National Eye Institute, Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland; National Human Genome Research Institute, Genetics and Molecular Biology Branch, Bethesda, Maryland; Office of the Clinical Director, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
National Eye Institute, Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Ophthalmology. 2018 Dec;125(12):1937-1952. doi: 10.1016/j.ophtha.2018.05.026. Epub 2018 Jul 25.
Joubert syndrome (JS) is caused by mutations in >34 genes that encode proteins involved with primary (nonmotile) cilia and the cilium basal body. This study describes the varying ocular phenotypes in JS patients, with correlation to systemic findings and genotype.
Patients were systematically and prospectively examined at the National Institutes of Health (NIH) Clinical Center in the setting of a dedicated natural history clinical trial.
Ninety-nine patients with JS examined at a single center.
All patients underwent genotyping for JS, followed by complete age-appropriate ophthalmic examinations at the NIH Clinical Center, including visual acuity (VA), fixation behavior, lid position, motility assessment, slit-lamp biomicroscopy, dilated fundus examination with an indirect ophthalmoscope, and retinoscopy. Color and fundus autofluorescence imaging, Optos wide-field photography (Dunfermline, Scotland, UK), and electroretinography (ERG) were performed when possible.
The VA (with longitudinal follow-up where possible), ptosis, extraocular muscle function, retinal and optic nerve status, and retinal function as measured by ERG.
Among patients with JS with quantifiable VA (68/99), values ranged from 0 logarithm of the minimum angle of resolution (logMAR) (Snellen 20/20) to 1.5 logMAR (Snellen 20/632). Strabismus (71/98), nystagmus (66/99), oculomotor apraxia (60/77), ptosis (30/98), coloboma (28/99), retinal degeneration (20/83), and optic nerve atrophy (8/86) were identified.
We recommend regular monitoring for ophthalmological manifestations of JS beginning soon after birth or diagnosis. We demonstrate delayed visual development and note that the amblyogenic time frame may last significantly longer in JS than is typical. In general, patients with coloboma were less likely to display retinal degeneration, and those with retinal degeneration did not have coloboma. Severe retinal degeneration that is early and aggressive is seen in disease caused by specific genes, such as CEP290- and AHI1-associated JS. Retinal degeneration in INPP5E-, MKS1-, and NPHP1-associated JS was generally milder. Finally, ptosis surgery can be helpful in a subset of patients with JS; decisions as to timing and benefit/risk ratio need to be made on an individual basis according to expert consultation.
杰伯综合征(JS)是由编码参与初级(非运动)纤毛和纤毛基体的蛋白的>34 个基因的突变引起的。本研究描述了 JS 患者不同的眼部表型,与系统发现和基因型相关。
在专门的自然病史临床试验中,患者在国立卫生研究院(NIH)临床中心进行系统和前瞻性检查。
在单一中心接受检查的 99 名 JS 患者。
所有患者均接受 JS 基因分型,然后在 NIH 临床中心进行全面的年龄匹配眼科检查,包括视力(VA)、固视行为、眼睑位置、运动评估、裂隙灯生物显微镜检查、间接检眼镜散瞳眼底检查和视网膜检影。尽可能进行彩色和眼底自发荧光成像、Optos 超广角摄影(苏格兰邓弗姆林)和视网膜电图(ERG)。
VA(如有可能进行纵向随访)、上睑下垂、眼外肌功能、视网膜和视神经状态以及 ERG 测量的视网膜功能。
在可定量 VA 的 JS 患者中(68/99),值范围从 0 对数最小分辨角(logMAR)(Snellen 20/20)到 1.5 logMAR(Snellen 20/632)。斜视(71/98)、眼球震颤(66/99)、眼球运动性失用(60/77)、上睑下垂(30/98)、视网膜脱离(28/99)、视神经萎缩(8/86)。
我们建议在出生或诊断后不久开始定期监测 JS 的眼部表现。我们发现视觉发育延迟,并注意到 JS 的弱视时间框架可能比典型情况长得多。一般来说,有视网膜脱离的患者不太可能出现视网膜变性,而有视网膜变性的患者没有视网膜脱离。在由特定基因引起的疾病中,如 CEP290-和 AHI1 相关的 JS,可观察到早期和侵袭性严重的视网膜变性。INPP5E-、MKS1-和 NPHP1 相关的 JS 中的视网膜变性通常较轻。最后,上睑下垂手术对 JS 的一部分患者可能有帮助;需要根据专家咨询,根据个体情况做出关于时间和收益/风险比的决策。